These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36266751)

  • 1. Berberine Attenuates Hyperuricemia by Regulating Urate Transporters and Gut Microbiota.
    Shan B; Wu M; Chen T; Tang W; Li P; Chen J
    Am J Chin Med; 2022; 50(8):2199-2221. PubMed ID: 36266751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
    Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
    Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model.
    Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y
    Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine Regulates the Metabolism of Uric Acid and Modulates Intestinal Flora in Hyperuricemia Rats Model.
    Chen Q; Li D; Wu F; He X; Zhou Y; Sun C; Wang H; Liu Y
    Comb Chem High Throughput Screen; 2023; 26(11):2057-2066. PubMed ID: 36424788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice.
    Wu X; Huang R; Ai G; Chen H; Ma X; Zhang J; Huang Q; Lao J; Zeng H; Li C; Xie J; Li Y; Su Z; Chen J; Huang X
    J Ethnopharmacol; 2024 Dec; 335():118606. PubMed ID: 39038504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis.
    Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y
    J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney targeting and modulating macrophage polarization through AMPK signaling: Therapeutic mechanism of berberine in uric acid nephropathy.
    Gong S; Chen J; Zheng X; Lu X; Chen M; Li J; Su Z; Liu Y; Chen J; Xie J; Xie Q; Li Y
    Int Immunopharmacol; 2024 Sep; 138():112632. PubMed ID: 38986300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data mining-guided alleviation of hyperuricemia by Paeonia veitchii Lynch through inhibition of xanthine oxidase and regulation of renal urate transporters.
    Du J; Wang N; Yu D; He P; Gao Y; Tu Y; Li Y
    Phytomedicine; 2024 Feb; 124():155305. PubMed ID: 38176275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
    Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
    BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice.
    Zhong L; Lin Y; Gong S; Wu X; Liu Y; Chen J; Li Y; Yan F; Su Z; Xie Q
    Phytomedicine; 2023 Jan; 108():154521. PubMed ID: 36334387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leech
    Liu X; Liang XQ; Lu TC; Feng Z; Zhang M; Liao NQ; Zhang FL; Wang B; Wang LS
    World J Gastroenterol; 2024 Aug; 30(29):3488-3510. PubMed ID: 39156502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
    Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
    Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis.
    Zhou X; Zhang B; Zhao X; Lin Y; Wang J; Wang X; Hu N; Wang S
    Food Funct; 2021 Jun; 12(12):5637-5649. PubMed ID: 34018499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
    Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
    Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine modulates gut microbiota to attenuate cerebral ferroptosis induced by ischemia-reperfusion in mice.
    Wang X; Zhang J; Wang S; Song Z; Sun H; Wu F; Lin X; Jin K; Jin X; Wang W; Lin Q; Wang F
    Eur J Pharmacol; 2023 Aug; 953():175782. PubMed ID: 37245860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome.
    Zhou X; Ji S; Chen L; Liu X; Deng Y; You Y; Wang M; He Q; Peng B; Yang Y; Chen X; Kwan HY; Zhou L; Chen J; Zhao X
    Microbiome; 2024 Jun; 12(1):109. PubMed ID: 38907332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice.
    Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D
    Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
    Yao Y; Chen H; Yan L; Wang W; Wang D
    Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice.
    Xu L; Lin G; Yu Q; Li Q; Mai L; Cheng J; Xie J; Liu Y; Su Z; Li Y
    Front Pharmacol; 2021; 12():645879. PubMed ID: 33959014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tea (
    Wu D; Chen R; Li Q; Lai X; Sun L; Zhang Z; Wen S; Sun S; Cao F
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.